Overview

Donor: Leprosy Research Initiative (LRI)
Application procedure: Letter of Inquiry
Donor base: Netherlands
Reference number: -
Eligible applicants: Individual, Non-Profit Organisation
Deadline: 23.01.2026

Financial details

Grant size: Small - up to $100,000
Minimum grant size: 10.000€
Total available budget: -
Funding type: Grants
Maximum grant size: 75.000€
Funding ratio: up to 100%

Sectors

  • Health
  • Research, Technology & Innovation
  • Social Inclusion
  • Water & Sanitation
  • Women & Gender

Project Locations

  1. Africa

      Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Democratic Republic of the Congo, Djibouti, Egypt, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea Bissau, Ivory Coast, Kenya, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Mauritius, Morocco, Mozambique, Namibia, Niger, Nigeria, Republic of the Congo, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tanzania, Togo, Tunisia, Uganda, Western Sahara, Zambia, Zimbabwe

  2. America

      Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominica, Dominican Republic, Ecuador, El Salvador, French Guiana, Grenada, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago, Uruguay, Venezuela

  3. Asia

      Afghanistan, Azerbaijan, Bahrain, Bangladesh, Bhutan, Brunei, Cambodia, China, East Timor, India, Indonesia, Iran, Iraq, Israel, Japan, Jordan, Kazakhstan, Korea, Kuwait, Kyrgyzstan, Laos, Lebanon, Malaysia, Maldives, Mongolia, Myanmar, Nepal, North Korea, Oman, Pakistan, Palestine, Philippines, Qatar, Russian Federation, Saudi Arabia, Singapore, South Korea, Sri Lanka, Syria, Taiwan, Tajikistan, Thailand, Turkey, Turkmenistan, United Arab Emirates, Uzbekistan, Vietnam, West Bank and Gaza, Yemen

  4. Europe

      Albania, Armenia, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Georgia, Hungary, Kosovo, Latvia, Lithuania, Moldova, Montenegro, North Macedonia, Poland, Romania, Serbia, Slovakia, Slovenia, Ukraine

  5. Pacific

      Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu

Description

1) Objective

The Leprosy Research Initiative (LRI) is pleased to announce an LRI Flagship call for proposals for funding commencing in 2027. LRI funds research with a focus on leprosy – including research applications combining leprosy with other neglected tropical diseases (NTDs) or other diseases or disabilities that share cross-cutting issues with leprosy.

For this budget round, preference will be given to research applications focusing on reactions and nerve function impairment. Researchers are encouraged to submit proposals addressing topics including, but not limited to:

  • Operational research on the diagnosis and management of reactions and nerve function impairment, including integration and strengthening of health systems and mainstreaming of services;
  • Research on the mechanisms of reactions;
  • Improved treatment regimens and assessment of new drugs;
  • Surveillance and follow-up post-treatment

2) Eligibility

Researchers interested to apply for funding by the LRI are invited to complete and submit a Letter of Intent (LoI), giving an outline of the intended research.

3) Location

Actions can take place worldwide.

4) Budget

There is no budget ceiling for the current call. By way of guidance: projects LRI has funded in the past years had an average annual budget of €30,000 (ranging from €10,000 to €75,000) – although in exceptional cases higher annual budgets have been accepted.

5) Application

LoIs should be submitted by January 23rd, 2026 at 17:00 (CET) after which the application portal will be closed.

Login Account

Already a Rubnio Customer?

Invaild email address.

6 or more characters, letters and numbers. Must contain at least one number.

Your information will nerver be shared with any third party.